JP7120382B2 - Method for producing copper compound fine particle-containing dispersion - Google Patents
Method for producing copper compound fine particle-containing dispersion Download PDFInfo
- Publication number
- JP7120382B2 JP7120382B2 JP2021078674A JP2021078674A JP7120382B2 JP 7120382 B2 JP7120382 B2 JP 7120382B2 JP 2021078674 A JP2021078674 A JP 2021078674A JP 2021078674 A JP2021078674 A JP 2021078674A JP 7120382 B2 JP7120382 B2 JP 7120382B2
- Authority
- JP
- Japan
- Prior art keywords
- boiling point
- dispersion
- point solvent
- fatty acid
- copper
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000006185 dispersion Substances 0.000 title claims description 90
- 239000005749 Copper compound Substances 0.000 title claims description 77
- 150000001880 copper compounds Chemical class 0.000 title claims description 77
- 239000010419 fine particle Substances 0.000 title claims description 65
- 238000004519 manufacturing process Methods 0.000 title claims description 32
- 239000002904 solvent Substances 0.000 claims description 101
- 238000009835 boiling Methods 0.000 claims description 93
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 86
- 239000000194 fatty acid Substances 0.000 claims description 86
- 229930195729 fatty acid Natural products 0.000 claims description 86
- 150000004665 fatty acids Chemical class 0.000 claims description 82
- 239000002245 particle Substances 0.000 claims description 42
- 239000007788 liquid Substances 0.000 claims description 30
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical group OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 claims description 27
- 239000003381 stabilizer Substances 0.000 claims description 27
- 229910052802 copper Inorganic materials 0.000 claims description 22
- 239000010949 copper Substances 0.000 claims description 22
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 21
- BERDEBHAJNAUOM-UHFFFAOYSA-N copper(I) oxide Inorganic materials [Cu]O[Cu] BERDEBHAJNAUOM-UHFFFAOYSA-N 0.000 claims description 18
- KRFJLUBVMFXRPN-UHFFFAOYSA-N cuprous oxide Chemical compound [O-2].[Cu+].[Cu+] KRFJLUBVMFXRPN-UHFFFAOYSA-N 0.000 claims description 18
- 229940112669 cuprous oxide Drugs 0.000 claims description 18
- 239000002270 dispersing agent Substances 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 238000002156 mixing Methods 0.000 claims description 15
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical group C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 claims description 13
- 235000019204 saccharin Nutrition 0.000 claims description 13
- 229940081974 saccharin Drugs 0.000 claims description 13
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 claims description 13
- 150000002334 glycols Chemical class 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 11
- 238000010438 heat treatment Methods 0.000 claims description 10
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 claims description 9
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 9
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical group CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 claims description 9
- OPQARKPSCNTWTJ-UHFFFAOYSA-L copper(ii) acetate Chemical compound [Cu+2].CC([O-])=O.CC([O-])=O OPQARKPSCNTWTJ-UHFFFAOYSA-L 0.000 claims description 5
- 238000000354 decomposition reaction Methods 0.000 claims description 5
- 230000000977 initiatory effect Effects 0.000 claims description 5
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- ODWXUNBKCRECNW-UHFFFAOYSA-M bromocopper(1+) Chemical compound Br[Cu+] ODWXUNBKCRECNW-UHFFFAOYSA-M 0.000 claims description 2
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 claims description 2
- 230000000840 anti-viral effect Effects 0.000 description 39
- -1 silver ions Chemical class 0.000 description 25
- 241000700605 Viruses Species 0.000 description 16
- QPLDLSVMHZLSFG-UHFFFAOYSA-N Copper oxide Chemical compound [Cu]=O QPLDLSVMHZLSFG-UHFFFAOYSA-N 0.000 description 15
- 239000011248 coating agent Substances 0.000 description 13
- 239000005751 Copper oxide Substances 0.000 description 12
- 239000003125 aqueous solvent Substances 0.000 description 12
- 238000000576 coating method Methods 0.000 description 12
- 229910000431 copper oxide Inorganic materials 0.000 description 12
- 238000000034 method Methods 0.000 description 9
- 239000004745 nonwoven fabric Substances 0.000 description 9
- 239000000047 product Substances 0.000 description 7
- 239000002612 dispersion medium Substances 0.000 description 6
- 239000004753 textile Substances 0.000 description 6
- 239000010408 film Substances 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 239000011347 resin Substances 0.000 description 5
- 229920005989 resin Polymers 0.000 description 5
- 239000011342 resin composition Substances 0.000 description 5
- 235000021355 Stearic acid Nutrition 0.000 description 4
- 238000004220 aggregation Methods 0.000 description 4
- 230000002776 aggregation Effects 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 239000008199 coating composition Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000001771 impaired effect Effects 0.000 description 4
- 239000011859 microparticle Substances 0.000 description 4
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 4
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- 239000008117 stearic acid Substances 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- JXSRRBVHLUJJFC-UHFFFAOYSA-N 7-amino-2-methylsulfanyl-[1,2,4]triazolo[1,5-a]pyrimidine-6-carbonitrile Chemical compound N1=CC(C#N)=C(N)N2N=C(SC)N=C21 JXSRRBVHLUJJFC-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 230000001747 exhibiting effect Effects 0.000 description 3
- 238000004020 luminiscence type Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000003973 paint Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000004062 sedimentation Methods 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 238000002441 X-ray diffraction Methods 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 230000003373 anti-fouling effect Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 239000011163 secondary particle Substances 0.000 description 2
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 239000004925 Acrylic resin Substances 0.000 description 1
- 229920000178 Acrylic resin Polymers 0.000 description 1
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 1
- 241001263478 Norovirus Species 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 108010003533 Viral Envelope Proteins Proteins 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 230000000274 adsorptive effect Effects 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000002216 antistatic agent Substances 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 229960005261 aspartic acid Drugs 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 150000003842 bromide salts Chemical class 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- YKDMBTQVKVEMSA-UHFFFAOYSA-N diethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOCCOC(=O)CCCCCCCCCCCCCCCCC YKDMBTQVKVEMSA-UHFFFAOYSA-N 0.000 description 1
- 229940111071 diethylene glycol distearate Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003759 ester based solvent Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 210000004779 membrane envelope Anatomy 0.000 description 1
- 150000002736 metal compounds Chemical class 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 229920006280 packaging film Polymers 0.000 description 1
- 239000012785 packaging film Substances 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 230000001699 photocatalysis Effects 0.000 description 1
- 229920001230 polyarylate Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 239000005871 repellent Substances 0.000 description 1
- 238000001878 scanning electron micrograph Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 238000001577 simple distillation Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Images
Landscapes
- Agricultural Chemicals And Associated Chemicals (AREA)
- Catalysts (AREA)
- Colloid Chemistry (AREA)
Description
本発明は、分散液の製造方法に関するものであり、より詳細には、抗ウイルス性を有する銅化合物粒子が分散媒中に安定に存在する分散液の製造方法に関する。 TECHNICAL FIELD The present invention relates to a method for producing a dispersion, and more particularly to a method for producing a dispersion in which antiviral copper compound particles are stably present in a dispersion medium.
従来より、抗菌性や抗ウイルス性を有する材料には、銀イオンや銅(II)イオンが有効成分として使用されており、これらの金属イオンをゼオライトやシリカゲルなどの物質に担持させ、或いは溶媒中に分散させて成る抗ウイルス材料が種々提案されている。
しかしながら、上記金属イオンは、インフルエンザウイルスのようなエンベロープ構造を有するウイルスに対する抗ウイルス性を発現することはできるが、ノロウイルスのようなエンベロープ構造を持たないウイルスに対しては抗ウイルス性を発現することはできなかった。
Conventionally, silver ions and copper (II) ions have been used as active ingredients in materials having antibacterial and antiviral properties. Various antiviral materials have been proposed which are dispersed in
However, although the above metal ions can exhibit antiviral properties against viruses having an envelope structure such as influenza virus, they do not exhibit antiviral properties against viruses without an envelope structure such as norovirus. I couldn't.
エンベロープ構造の有無にかかわらず、抗ウイルス性を発現可能な金属化合物として一価銅化合物も知られており、例えば、下記特許文献1には、一価の銅化合物微粒子と、還元剤と、分散媒を含有し、pH6以下であることを特徴とする抗ウイルス組成物が記載されている。下記特許文献2には、BET比表面積が5~100m2/gの亜酸化銅粒子と、アルデヒド基を有する糖類と、光触媒物質とを含有することを特徴とする抗菌抗ウイルス性組成物が記載されている。下記特許文献3には、銅粒子及び銅化合物粒子の少なくともいずれか一方を酸化物粒子に担持した、平均二次粒子径が80nm~600nmの銅担持酸化物と、平均二次粒子径が1μm~15μmの硫酸バリウムと撥水性の樹脂バインダーとを有する抗ウイルス性塗膜が記載されている。 A monovalent copper compound is also known as a metal compound capable of exhibiting antiviral properties regardless of the presence or absence of an envelope structure. An antiviral composition is described which contains a medium and is characterized by a pH of 6 or less. Patent Document 2 below describes an antibacterial and antiviral composition characterized by containing cuprous oxide particles having a BET specific surface area of 5 to 100 m 2 /g, sugars having an aldehyde group, and a photocatalytic substance. It is In Patent Document 3 below, at least one of copper particles and copper compound particles is supported on oxide particles, and a copper-supported oxide having an average secondary particle size of 80 nm to 600 nm and an average secondary particle size of 1 μm to An antiviral coating with 15 μm barium sulphate and a water-repellent resin binder is described.
しかしながら、非水系溶媒中では、抗ウイルス性を有する一価銅化合物の微粒子は凝集しやすく、一価銅化合物を均一に分散させることは困難であり、分散液を抗ウイルス組成物として利用する場合や塗料と混合してコーティングされた抗ウイルス成型体として用いる場合において、一価銅化合物の微粒子が有する抗ウイルス性を効率よく発現することが困難であった。
また、上記特許文献で挙げられている粒子径の大きい一価銅化合物を用いた場合には、粒子表面積が小さくなり、ウイルスとの接触機会が減少することで抗ウイルス性が低下する。また、粒子径の大きい一価銅化合物がコーティングされた抗ウイルス成型体では、ヘイズや光透過率が悪化して透明性が損なわれるという問題がある。
更に、一価銅化合物の微粒子は粉砕することによっても得られるが、被膜剤や安定化剤がないため凝集しやすく、亜酸化銅から酸化銅(II)への酸化が起こりやすいといった問題もある。
However, in a non-aqueous solvent, fine particles of a monovalent copper compound having antiviral properties tend to aggregate, making it difficult to uniformly disperse the monovalent copper compound. When used as an antiviral molded article coated by mixing with or paint, it was difficult to efficiently express the antiviral properties of the microparticles of the monovalent copper compound.
In addition, when the monovalent copper compound having a large particle size, which is mentioned in the above patent document, is used, the particle surface area becomes small, and the chance of contact with the virus is reduced, thereby lowering the antiviral properties. In addition, an antiviral molded article coated with a monovalent copper compound having a large particle size has a problem that haze and light transmittance are deteriorated and transparency is impaired.
Furthermore, fine particles of monovalent copper compounds can also be obtained by pulverization, but there is also a problem that they tend to aggregate because there is no coating agent or stabilizer, and oxidation of cuprous oxide to copper (II) oxide easily occurs. .
従って本発明の目的は、銅化合物、特に一価銅化合物の微粒子が有する抗ウイルス性を効率よく発現可能な、銅化合物の微粒子が分散媒中に均一且つ安定的に分散する分散液の製造方法を提供することである。 Accordingly, an object of the present invention is to provide a method for producing a dispersion liquid in which fine particles of a copper compound are uniformly and stably dispersed in a dispersion medium, and which can efficiently exhibit antiviral properties possessed by fine particles of a copper compound, particularly a monovalent copper compound. is to provide
本発明によれば、高沸点溶媒としてグリコール類を使用し、該高沸点溶媒に脂肪酸銅と安定化剤を添加し、これを水の存在下で前記脂肪酸銅の分解開始温度未満の温度で加熱混合することにより、脂肪酸で被覆された亜酸化銅微粒子が分散すると共に安定化剤を含んで成る高沸点溶媒分散液を調製し、該高沸点溶媒分散液を、予め分散剤を配合した低沸点溶媒と混合した後、前記高沸点溶媒及び低沸点溶媒を二相分離すると共に、高沸点溶媒から低沸点溶媒中に脂肪酸で被覆された亜酸化銅微粒子を抽出することを特徴とする亜酸化銅微粒子が分散して成る分散液の製造方法が提供される。 According to the present invention, glycols are used as a high boiling point solvent, fatty acid copper and a stabilizer are added to the high boiling point solvent, and this is heated in the presence of water at a temperature below the decomposition initiation temperature of the fatty acid copper. By mixing, the cuprous oxide fine particles coated with fatty acid are dispersed and a high boiling point solvent dispersion containing a stabilizer is prepared, and the high boiling point solvent dispersion is mixed with a low boiling point dispersant in advance. After mixing with a solvent, the high boiling point solvent and the low boiling point solvent are separated into two phases, and cuprous oxide particles coated with fatty acids are extracted from the high boiling point solvent into the low boiling point solvent. Provided is a method for producing a dispersion in which fine particles are dispersed.
本発明によればまた、高沸点溶媒としてグリコール類を使用し、該高沸点溶媒に、脂肪酸、銅化合物及び安定化剤を添加し、これを180~230℃の温度で加熱混合することにより、脂肪酸で被覆された銅化合物微粒子が分散すると共に安定化剤を含んで成る高沸点溶媒分散液を調製し、該高沸点溶媒分散液を、予め分散剤を配合した低沸点溶媒と混合した後、前記高沸点溶媒及び低沸点溶媒を二相分離すると共に、高沸点溶媒から低沸点溶媒中に脂肪酸で被覆された銅化合物微粒子を抽出することを特徴とする銅化合物微粒子が分散して成る分散液の製造方法が提供される。 According to the present invention, glycols are used as a high boiling point solvent, a fatty acid, a copper compound and a stabilizer are added to the high boiling point solvent, and this is heated and mixed at a temperature of 180 to 230 ° C. to obtain After preparing a high boiling point solvent dispersion in which copper compound fine particles coated with fatty acids are dispersed and containing a stabilizer, and mixing the high boiling point solvent dispersion with a low boiling point solvent in which a dispersant is previously blended, A dispersion liquid in which copper compound fine particles are dispersed, wherein the high boiling point solvent and the low boiling point solvent are separated into two phases, and the copper compound fine particles coated with fatty acid are extracted from the high boiling point solvent into the low boiling point solvent. is provided.
本発明の分散液の上記製造方法においては、
1.前記高沸点溶媒分散液の調製における加熱混合を、水の存在下で行うこと、
2.前記銅化合物が、酢酸銅、塩化銅、臭化銅の何れかであること、
3.前記高沸点溶媒がジエチレングリコールであり、前記低沸点溶媒が酢酸ブチルであること、
4.前記安定化剤が、サッカリンであること、
が好適である。
In the method for producing the dispersion of the present invention,
1. Heating and mixing in the preparation of the high boiling point solvent dispersion in the presence of water;
2. The copper compound is any one of copper acetate, copper chloride, and copper bromide;
3. wherein the high boiling solvent is diethylene glycol and the low boiling solvent is butyl acetate;
4. the stabilizing agent is saccharin;
is preferred.
本発明によれば更に、グリコール類に、脂肪酸銅とサッカリンを添加し、これを水の存在下で前記脂肪酸銅の分解開始温度未満の温度で加熱混合することにより脂肪酸銅を分解して、亜酸化微粒子が分散すると共にサッカリンを含有して成る分散液を製造することを特徴とするグリコール分散液の製造方法が提供される。 Further, according to the present invention, fatty acid copper and saccharin are added to glycols, and the mixture is heated and mixed in the presence of water at a temperature below the decomposition initiation temperature of the fatty acid copper to decompose the fatty acid copper. There is provided a method for producing a glycol dispersion, characterized by producing a dispersion comprising saccharin in which oxidized fine particles are dispersed .
本発明の分散液においては、銅化合物微粒子が脂肪酸、好適には脂肪酸と該脂肪酸のエステル化合物で被覆されていることにより、非水系溶媒中に高濃度で含有されている場合にも凝集することなく均一に分散するため、銅化合物微粒子が有する優れた特性を効率よく発現することができる。特に、銅化合物が一価銅化合物であることにより、前述したとおり、エンベロープ構造を持たないウイルスに対しても抗ウイルス性を効率よく発現することが可能になる。
また本発明の分散液においては、分散液中に配合された安定化剤が、銅化合物微粒子に保護層として配位していると考えられ、これにより、安定性に劣る一価銅化合物であっても、一価の状態を安定的に維持可能であり、上記脂肪酸による被覆、更にこの脂肪酸のエステル化合物による被覆と相俟って、銅化合物微粒子が非水系溶媒中に沈降することなく均一に分散していることから、塗料組成物や樹脂組成物などの希釈溶媒として好適に使用することができ、これにより各種性能を塗膜や樹脂成形体に付与することが可能になる。
In the dispersion of the present invention, since the fine copper compound particles are coated with a fatty acid, preferably a fatty acid and an ester compound of the fatty acid, aggregation does not occur even when the copper compound fine particles are contained in a non-aqueous solvent at a high concentration. Since the copper compound fine particles are dispersed uniformly, the excellent properties of the copper compound fine particles can be efficiently exhibited. In particular, when the copper compound is a monovalent copper compound, as described above, it is possible to efficiently exhibit antiviral properties even against viruses that do not have an envelope structure.
Further, in the dispersion of the present invention, the stabilizer contained in the dispersion is thought to be coordinated with the copper compound fine particles as a protective layer. However, the monovalent state can be stably maintained, and together with the coating with the fatty acid and the coating with the ester compound of this fatty acid, the copper compound fine particles are uniformly dispersed in the non-aqueous solvent without sedimentation. Since it is dispersed, it can be suitably used as a diluting solvent for coating compositions, resin compositions, etc., and thereby it becomes possible to impart various properties to coating films and resin moldings.
更に本発明の分散液の製造方法においては、高沸点溶媒中に脂肪酸銅と安定化剤を配合して加熱することにより、亜酸化銅微粒子の表面に脂肪酸、好適には脂肪酸と該脂肪酸のエステル化合物が配位された亜酸化銅微粒子を形成することが可能になり、かかる亜酸化銅微粒子は、低沸点溶媒に対して優れた親和性を有することから、亜酸化銅微粒子は高沸点溶媒から簡単な操作で効率よく低沸点溶媒に抽出され、低沸点溶媒中に亜酸化銅微粒子を高濃度で存在させることが可能になる。
特に本発明の製造方法において、高沸点溶媒分散液を調製する際、水の存在下で加熱混合を行うことによって、一価銅化合物粒子を調製することが可能になり、前述したとおり、エンベロープ構造の有無にかかわらず優れた抗ウイルス性を発現可能な一価銅化合物粒子を含有する分散液を提供することが可能になる。
尚、本明細書において、抗ウイルス性とは、ウイルスを不活性化させることを意味する。
Furthermore, in the method for producing a dispersion of the present invention, a fatty acid copper and a stabilizer are blended in a high-boiling solvent and heated to coat the surface of the cuprous oxide fine particles with a fatty acid, preferably a fatty acid and an ester of the fatty acid. It is possible to form cuprous oxide fine particles in which the compound is coordinated, and such cuprous oxide fine particles have excellent affinity for low boiling point solvents, so that cuprous oxide fine particles can be removed from high boiling point solvents. It can be efficiently extracted into a low boiling point solvent by a simple operation, and the cuprous oxide fine particles can be present at a high concentration in the low boiling point solvent.
In particular, in the production method of the present invention, when preparing the high-boiling-point solvent dispersion, it is possible to prepare monovalent copper compound particles by heating and mixing in the presence of water, and as described above, the envelope structure It is possible to provide a dispersion containing monovalent copper compound particles capable of exhibiting excellent antiviral properties regardless of the presence or absence of
As used herein, the term "antiviral" means to inactivate viruses.
(分散液)
本発明の分散液は、上述したとおり、非水系溶媒中に脂肪酸で被覆された銅化合物微粒子、すなわち一価銅化合物粒子又は二価銅化合物粒子と、安定化剤とを含有することを特徴とするものである。
(dispersion liquid)
As described above, the dispersion of the present invention is characterized by containing fatty acid-coated copper compound fine particles, that is, monovalent copper compound particles or divalent copper compound particles, and a stabilizer in a non-aqueous solvent. It is something to do.
[銅化合物微粒子]
本発明の分散液において、抗ウイルス性を示す有効成分である銅化合物は、一価銅化合物又は二価銅化合物であり、これらはいずれもウイルスを吸着してウイルスを不活性化することが可能であるが、二価銅化合物は、エンベロープ構造を有するウイルスには抗ウイルス性を有するが、一価銅化合物はウイルスのエンベロープの有無にかかわらず抗ウイルス性を発現することができる。
銅化合物としては、酸化物、酢酸化合物、塩化物、臭化物、水酸化物、シアン化物等を例示することができ、これらの中でも、亜酸化銅であることが特に好適である。
本発明において銅化合物微粒子は表面が脂肪酸で被覆されているが、特に脂肪酸と共にこの脂肪酸のエステル化合物で被覆されていることが好ましく、これにより、銅化合物微粒子の表面活性が高まることに起因する微粒子表面の酸化が防止されると共に、微粒子の凝集を抑制することが可能になる。特に一価銅化合物粒子は表面活性が高く、酸化されやすく凝集しやすいが、脂肪酸と脂肪酸のエステル化合物で被覆されていることにより、分散液中で均一に分散し、優れた抗ウイルス性を発現できる。
更に本発明の分散液に含まれる銅化合物微粒子は、抗ウイルス性の他、抗菌性、導電性、紫外線遮蔽性、防汚性などを有している。
[Copper compound fine particles]
In the dispersion of the present invention, the copper compound, which is an active ingredient exhibiting antiviral properties, is a monovalent copper compound or a divalent copper compound, both of which are capable of adsorbing and inactivating viruses. However, divalent copper compounds have antiviral properties against viruses having an envelope structure, whereas monovalent copper compounds can exhibit antiviral properties regardless of the presence or absence of a viral envelope.
Examples of copper compounds include oxides, acetate compounds, chlorides, bromides, hydroxides, cyanides, etc. Among these, cuprous oxide is particularly preferred.
In the present invention, the surface of the copper compound fine particles is coated with a fatty acid, and it is particularly preferable that the surface of the copper compound fine particles is coated with an ester compound of the fatty acid together with the fatty acid. The oxidation of the surface is prevented, and aggregation of fine particles can be suppressed. In particular, monovalent copper compound particles have high surface activity and are easily oxidized and easily aggregated, but because they are coated with fatty acids and fatty acid ester compounds, they disperse uniformly in the dispersion liquid and exhibit excellent antiviral properties. can.
Furthermore, the copper compound fine particles contained in the dispersion of the present invention have antiviral properties, as well as antibacterial properties, conductivity, ultraviolet shielding properties, antifouling properties, and the like.
銅化合物微粒子表面を被覆する脂肪酸としては、ミリスチン酸,ステアリン酸,オレイン酸,パルミチン酸,n-デカン酸,パラトイル酸,コハク酸,マロン酸,酒石酸,リンゴ酸,グルタル酸,アジピン酸、酢酸等を例示することができ、これらは複数種の組み合わせであってもよいが、特にステアリン酸であることが好適である。
また上記脂肪酸のエステル化合物としては、後述する高沸点溶媒とのエステル化合物であり、例えば脂肪酸がステアリン酸、高沸点溶媒としてジエチレングリコールの場合には、ジステアリン酸ジエチレングリコールやジステアリン酸エチレングリコール等が挙げられる。前述したとおり、脂肪酸による被覆と共に、この脂肪酸のエステル化合物が被覆されていることにより、脂肪酸のみが被覆されている場合よりも、上述した作用効果を顕著に得ることができる。
Fatty acids that coat the surfaces of copper compound fine particles include myristic acid, stearic acid, oleic acid, palmitic acid, n-decanoic acid, paratoic acid, succinic acid, malonic acid, tartaric acid, malic acid, glutaric acid, adipic acid, and acetic acid. can be exemplified, and these may be a combination of multiple types, but stearic acid is particularly preferred.
The ester compound of the above fatty acid is an ester compound with a high boiling point solvent, which will be described later. For example, when the fatty acid is stearic acid and the high boiling point solvent is diethylene glycol, diethylene glycol distearate, ethylene glycol distearate, and the like can be mentioned. As described above, the coating with the fatty acid ester compound together with the coating with the fatty acid makes it possible to obtain the above effects more significantly than when only the fatty acid is coated.
本発明において銅化合物微粒子の平均粒径は、1~200nmの範囲にあることが好適であり、本発明の分散液中においては、銅化合物微粒子は高濃度であっても凝集することなく均一に分散していることから、銅微粒子が上記範囲にあることと相俟って、優れた抗ウイルス性能を効率よく発現することが可能になる。尚、本明細書でいう平均粒径とは、銅化合物微粒子と銅化合物微粒子との間に隙間がないものを一つの粒子とし、その平均をとったものをいう。
脂肪酸、好適には脂肪酸と該脂肪酸のエステル化合物の両方で表面が被覆された銅化合物微粒子が、分散液中に0.01~2重量%、特に0.05~1重量%の量で含有されていることが好ましい。上記範囲よりも銅化合物微粒子の量が少ない場合には上記範囲にある場合に比して、十分な抗ウイルス性能を発現することができず、一方上記範囲よりも銅化合物微粒子の量が多い場合には、上記範囲にある場合に比して経済性が劣るだけでなく、塗料組成物や樹脂組成物に使用した場合に塗工性や成形性等が損なわれるおそれがある。
In the present invention, the average particle diameter of the copper compound fine particles is preferably in the range of 1 to 200 nm. Since it is dispersed, it is possible to efficiently express excellent antiviral performance, coupled with the fact that the copper fine particles are in the above range. The average particle size as used in the present specification is the average of particles having no gaps between copper compound fine particles.
Copper compound fine particles whose surfaces are coated with both a fatty acid, preferably a fatty acid and an ester compound of the fatty acid, are contained in the dispersion in an amount of 0.01 to 2% by weight, particularly 0.05 to 1% by weight. preferably. When the amount of copper compound fine particles is less than the above range, sufficient antiviral performance cannot be exhibited compared to when it is within the above range, whereas when the amount of copper compound fine particles is greater than the above range. In this range, not only the economy is inferior to that in the case of the above range, but also the coatability, moldability, etc. may be impaired when used in a coating composition or a resin composition.
[安定化剤]
本発明の分散液においては、分散液中に安定化剤が含有されていることにより、銅化合物微粒子が一価又は二価の状態に安定に維持される。また銅化合物微粒子が脂肪酸で表面を被覆されて、酸化されにくくなっていることと相俟って、銅化合物微粒子を長期にわたって安定して分散液中に存在させることが可能になる。安定化剤は、用いる非水系溶媒によっては溶解している場合もあるが、銅化合物微粒子に配位していると考えられる。
このような安定化剤としては、サッカリン、サリチル酸、アスパラギン酸、クエン酸等を例示することができるが、サッカリンを好適に使用することができる。
安定化剤は、分散液中に0.01~0.1重量%、特に0.02~0.05重量%の量で含有されていることが好ましい。上記範囲よりも安定化剤の量が少ない場合には上記範囲にある場合に比して銅化合物微粒子の安定性が損なわれるおそれがあり、一方上記範囲よりも安定化剤の量が多くとも経済性に劣るだけで更なる効果は望めない。
[Stabilizer]
In the dispersion liquid of the present invention, the copper compound fine particles are stably maintained in a monovalent or divalent state by containing a stabilizer in the dispersion liquid. In addition, since the surfaces of the copper compound fine particles are coated with fatty acid, the copper compound fine particles can be stably present in the dispersion liquid for a long period of time. Although the stabilizer may be dissolved depending on the non-aqueous solvent used, it is considered to be coordinated with the fine copper compound particles.
Examples of such stabilizers include saccharin, salicylic acid, aspartic acid, citric acid and the like, and saccharin is preferably used.
The stabilizer is preferably contained in the dispersion in an amount of 0.01-0.1% by weight, in particular 0.02-0.05% by weight. If the amount of the stabilizer is less than the above range, the stability of the copper compound fine particles may be impaired compared to the case of the above range. Further effects cannot be expected just by being inferior in terms of performance.
[非水系溶媒]
本発明の分散液における非水系溶媒としては、酢酸メチル、酢酸エチル、酢酸ブチル等のエステル類、ヘキサン、ヘプタン、トルエン、キシレン、シクロヘキサン等の炭化水素類、メチルイソブチルケトン、メチルエチルケトン、シクロヘキサノン等のケトン類等の低沸点溶媒を例示することができるが、エステル系溶媒が好ましく、特に酢酸ブチルが好適である。
本発明の分散液においては、非水系溶媒が上記の低沸点溶媒であることにより、疎水性の塗料組成物や樹脂組成物の希釈剤として有効に利用することが可能になる。
[Non-aqueous solvent]
Examples of non-aqueous solvents in the dispersion of the present invention include esters such as methyl acetate, ethyl acetate and butyl acetate; hydrocarbons such as hexane, heptane, toluene, xylene and cyclohexane; and ketones such as methyl isobutyl ketone, methyl ethyl ketone and cyclohexanone. Examples of low-boiling point solvents such as the above can be exemplified, but ester-based solvents are preferred, and butyl acetate is particularly preferred.
In the dispersion liquid of the present invention, since the non-aqueous solvent is the low boiling point solvent, it can be effectively used as a diluent for hydrophobic coating compositions and resin compositions.
[その他]
本発明の分散液には、上述した銅化合物微粒子及び安定化剤の他、分散剤を含有していることが好適である。これにより、銅化合物微粒子を高濃度で含有する場合にも、銅化合物微粒子が均一に分散された分散液とすることが可能になる。
分散剤としては、吸着基に、1級、2級、3級アミン又はその対イオンを中和したアミン塩、カルボン酸又はカルボン酸塩、水酸基のいずれか1種類以上を有し、主査及び側鎖に、脂肪酸、ポリエーテル、ポリエステル、ポリウレタン、ポリアリレートを有する高分子分散剤を使用することができる。
これらの分散剤は、吸着基を有することで上記銅化合物微粒子の表面に吸着し、主鎖又は側鎖により非水系溶媒との相溶性を向上させ、高分子鎖の立体障害による斥力が生じ、銅化合物微粒子の凝集が抑制され、非水系溶媒中に均一に分散させ、経時による凝集を解消することができる。
高分子分散剤としては、主鎖のみで構成されているタイプや側鎖を有するくし型構造タイプ、星型構造を有するタイプを使用することができる。
分散剤は、分散液中に0.01~2重量%、特に0.1~1重量%の量で含有されていることが好ましい。上記範囲よりも分散剤の量が少ない場合には上記範囲にある場合に比して銅化合物微粒子の分散性に更なる向上が望めず、一方上記範囲よりも分散剤の量が多くとも更なる効果の向上は望めないと共に経済性にも劣るようになる。
本発明の分散液には、従来公知の添加剤、例えば、酸化防止剤、紫外線吸収剤、帯電防止剤、染料等を従来公知の処方に従って配合することもできる。
[others]
The dispersion liquid of the present invention preferably contains a dispersing agent in addition to the fine copper compound particles and the stabilizing agent described above. As a result, even when the copper compound fine particles are contained at a high concentration, a dispersion liquid in which the copper compound fine particles are uniformly dispersed can be obtained.
As a dispersant, the adsorbing group has at least one of primary, secondary, tertiary amines or amine salts obtained by neutralizing counterions thereof, carboxylic acids or carboxylates, and hydroxyl groups. Polymeric dispersants having fatty acids, polyethers, polyesters, polyurethanes, polyarylates in the chain can be used.
These dispersants have adsorptive groups to adsorb to the surface of the copper compound fine particles, improve compatibility with non-aqueous solvents by main chains or side chains, and generate repulsive force due to steric hindrance of polymer chains. Aggregation of the copper compound fine particles is suppressed, and the particles can be uniformly dispersed in the non-aqueous solvent to eliminate aggregation over time.
As the polymeric dispersant, a type consisting only of a main chain, a comb structure type having side chains, and a type having a star structure can be used.
The dispersant is preferably contained in the dispersion in an amount of 0.01 to 2% by weight, especially 0.1 to 1% by weight. When the amount of the dispersing agent is less than the above range, the dispersibility of the copper compound fine particles cannot be expected to be further improved compared to the case of being within the above range. An improvement in the effect cannot be expected, and the economic efficiency is also inferior.
Conventionally known additives such as antioxidants, ultraviolet absorbers, antistatic agents, dyes, etc. can also be added to the dispersion of the present invention according to conventionally known formulations.
本発明の分散液は、繊維製品等を構成する樹脂組成物に希釈剤として含有させる、或いは繊維製品等に直接塗布或いは含浸させることにより、或いは繊維製品等にバインダー樹脂と分散液を混合したものを塗布させることにより、繊維製品等に抗ウイルス性を付与することが可能になる。
本発明の分散液を用いた繊維製品としては、マスク、エアコンフィルター、空気清浄機用フィルター、衣服、作業服、カーテン、カーペット、自動車用部材、シーツ、タオル、ワイパーなどの掃除用品などが挙げられる。
本発明の分散液は、塗料と混合して塗工することでコーティング加工により、フィルムやシート、金属基板上に含有させることができ、基材表面或いは外面に抗ウイルス性を付与することができる。
例えば、医療用具、医療用具の包装フィルム、廃棄容器、ゴミ袋、介護施設或いは病院や学校などの公共施設の壁材や床材、ワックスコート材、吐しゃ物の処理用具などが挙げられる。
The dispersion of the present invention can be obtained by adding a diluent to the resin composition constituting the textile product, etc., by directly coating or impregnating the textile product, etc., or by mixing the binder resin and the dispersion into the textile product, etc. By applying this, it is possible to impart antiviral properties to textile products and the like.
Examples of textile products using the dispersion of the present invention include masks, air conditioner filters, air purifier filters, clothes, work clothes, curtains, carpets, automobile members, sheets, towels, cleaning supplies such as wipers, and the like. .
The dispersion of the present invention can be incorporated on a film, sheet, or metal substrate by coating by mixing with a paint, and can impart antiviral properties to the surface or outer surface of the substrate. .
Examples include medical devices, packaging films for medical devices, waste containers, garbage bags, wall materials and floor materials for public facilities such as nursing homes, hospitals and schools, wax coating materials, and tools for treating vomit.
(分散液の第一の製造方法)
本発明の低沸点溶媒中に脂肪酸で被覆された酸化銅微粒子が分散された分散液の製造方法は以下の方法によって調製することができる。
(1)第一工程
脂肪酸銅と安定化剤を高沸点溶媒に添加し、これを加熱することにより、脂肪酸、好適には脂肪酸と該脂肪酸のエステル化合物の両方で表面が被覆された酸化銅微粒子が分散すると共に、安定化剤を含んで成る高沸点溶媒分散液を調製する。
この際、高沸点溶媒と共に水を含有させることによって、酸化銅微粒子を一価の亜酸化銅微粒子に調製することが可能となる。
加熱温度は、用いる脂肪酸銅の分解開始温度未満の温度であり、具体的には180~230℃の範囲であることが好ましい。加熱混合の時間は、120~360分であることが好適である。
脂肪酸銅の配合量は、高沸点溶媒100重量部当たり0.1~5重量部の範囲にあることが好ましい。上記範囲よりも脂肪酸銅の量が少ない場合には、上記範囲にある場合に比して十分な抗ウイルス性を分散液に付与することができないおそれがある。一方上記範囲よりも脂肪酸銅の量が多い場合には上記範囲にある場合に比して、経済性が劣ると共に塗工性や成形性が損なわれるおそれがある。
また水の配合量は、高沸点溶媒100重量部当たり0.1~5重量部の範囲にあることが好ましい。上記範囲よりも水の量が少ない場合には、亜酸化銅の生成量が低下し、その一方上記範囲よりも多いと、亜酸化銅の生成速度が速くなり、粒子径が大きくなってしまう。
また安定化剤の配合量は、高沸点溶媒100重量部当たり0.01~0.1重量部の範囲にあることが好ましい。上記範囲よりも安定化剤の量が少ない場合には、上記範囲にある場合に比して酸化銅を長期にわたって安定化できないおそれがあり、一方上記範囲よりも安定化剤の量が多い場合には、上記範囲にある場合に比して酸化銅微粒子の安定性の更なる向上も得られず経済性に劣るおそれがある。
高沸点溶媒としては、エチレングリコール、ジエチレングリコール、トリエチレングリコール、ポリエチレングリコール等のグリコール類を挙げることができ、後述する低沸点溶媒との組み合わせで適宜選択する。
(First method for producing a dispersion)
The method for producing a dispersion of the present invention in which copper oxide fine particles coated with fatty acid are dispersed in a low boiling point solvent can be prepared by the following method.
(1)
At this time, by containing water together with the high-boiling solvent, it is possible to prepare the fine copper oxide particles into monovalent cuprous oxide fine particles.
The heating temperature is a temperature lower than the decomposition initiation temperature of the fatty acid copper used, specifically in the range of 180 to 230°C. The time for heating and mixing is preferably 120 to 360 minutes.
The amount of fatty acid copper compounded is preferably in the range of 0.1 to 5 parts by weight per 100 parts by weight of the high boiling point solvent. If the amount of fatty acid copper is less than the above range, it may not be possible to impart sufficient antiviral properties to the dispersion compared to the case where the amount is within the above range. On the other hand, when the amount of fatty acid copper is larger than the above range, the economy is inferior and the coatability and moldability may be impaired as compared with the case where the amount is within the above range.
The amount of water to be blended is preferably in the range of 0.1 to 5 parts by weight per 100 parts by weight of the high boiling point solvent. If the amount of water is less than the above range, the amount of cuprous oxide produced decreases, while if the amount is larger than the above range, the production rate of cuprous oxide increases and the particle size increases.
The amount of the stabilizer to be blended is preferably in the range of 0.01 to 0.1 parts by weight per 100 parts by weight of the high boiling point solvent. If the amount of the stabilizer is less than the above range, the copper oxide may not be stabilized for a long period of time compared to the case of the above range. When the ratio is within the above range, the stability of the copper oxide fine particles cannot be further improved, and there is a risk of being inferior in economic efficiency.
Examples of high boiling point solvents include glycols such as ethylene glycol, diethylene glycol, triethylene glycol, and polyethylene glycol, which are appropriately selected in combination with low boiling point solvents described later.
(2)第二工程
次いで、脂肪酸、好適には脂肪酸と該脂肪酸のエステル化合物で被覆された酸化銅微粒子が分散すると共に、安定化剤を含んで成る高沸点溶媒分散液と、予め分散剤を配合した低沸点溶媒とを混合し、混合液を調製する。
低沸点溶媒は、高沸点溶媒100重量部に対して10~200重量部の量で高沸点溶媒分散液に添加することが好ましい。尚、低沸点溶媒中の分散剤の配合量は、高沸点溶媒分散液中の脂肪酸、好適には脂肪酸と該脂肪酸のエステル化合物で被覆された酸化銅微粒子の量によって異なるが、低沸点溶媒100重量部当たり0.01~2重量部の量であることが好ましい。
低沸点溶媒としては、前述した分散液の非水系溶媒を用いることができる。低沸点溶媒は、高沸点溶媒と相溶しないことが重要であり、高沸点溶媒と低沸点溶媒の溶解度パラメータ(Sp値)の差が3以上となるように組み合わせることが好ましい。
好適には、高沸点溶媒としてジエチレングリコール(Sp値:12.6)を用いた場合には、低沸点溶媒として酢酸ブチル(Sp値:8.4)を用いることが望ましい。
(2) Second step Next, the copper oxide fine particles coated with a fatty acid, preferably a fatty acid and an ester compound of the fatty acid are dispersed, and a high boiling point solvent dispersion containing a stabilizer and a dispersant are added in advance. A mixed solution is prepared by mixing with the blended low boiling point solvent.
The low boiling point solvent is preferably added to the high boiling point solvent dispersion in an amount of 10 to 200 parts by weight per 100 parts by weight of the high boiling point solvent. The amount of the dispersant in the low boiling point solvent varies depending on the amount of the fatty acid in the high boiling point solvent dispersion, preferably the amount of the copper oxide fine particles coated with the fatty acid and the ester compound of the fatty acid. An amount of 0.01 to 2 parts by weight is preferred.
As the low-boiling-point solvent, a non-aqueous solvent for the dispersion can be used. It is important that the low boiling point solvent is not compatible with the high boiling point solvent, and it is preferable to combine the high boiling point solvent and the low boiling point solvent so that the difference in solubility parameter (Sp value) is 3 or more.
Preferably, when diethylene glycol (Sp value: 12.6) is used as the high boiling point solvent, butyl acetate (Sp value: 8.4) is preferably used as the low boiling point solvent.
(3)第三工程
上記混合液を、0~40℃の温度で30~120分間静置することにより、高沸点溶媒及び低沸点溶媒を相分離させる。混合液が相分離されると、混合液中に存在していた脂肪酸、好適には脂肪酸及び該脂肪酸のエステル化合物で被覆された酸化銅微粒子が低沸点溶媒側に抽出される。特に本発明においては低沸点溶媒に分散剤が配合されていることから、分散剤の吸着基が酸化銅微粒子に配位することにより、酸化銅微粒子は低沸点溶媒へ抽出されやすくなる。
次いで、相分離された混合液から高沸点溶媒を除去することにより、低沸点溶媒中に脂肪酸、好適には脂肪酸及び該脂肪酸のエステル化合物で被覆された酸化銅微粒子が分散された分散液を得ることができる。
高沸点溶媒の除去は、単蒸留、減圧蒸留、精密蒸留、薄膜蒸留、抽出、膜分離等の、従来公知の方法によって行うことができる。
尚、前記第一工程において、高沸点溶媒に、脂肪酸銅及び安定化剤と共に、塩化ナトリウム、臭化ナトリウム等を配合することにより、分散液中に分散する銅化合物微粒子を、銅のハロゲン化物微粒子とすることができる。
(3) Third step The mixed solution is allowed to stand at a temperature of 0 to 40°C for 30 to 120 minutes, thereby phase-separating the high boiling point solvent and the low boiling point solvent. When the mixed liquid is phase-separated, the fatty acid present in the mixed liquid, preferably the copper oxide fine particles coated with the fatty acid and the ester compound of the fatty acid, are extracted to the low boiling point solvent side. In particular, in the present invention, since the dispersant is blended with the low boiling point solvent, the adsorption groups of the dispersant are coordinated with the copper oxide fine particles, making it easier for the copper oxide fine particles to be extracted into the low boiling point solvent.
Next, by removing the high boiling point solvent from the phase-separated mixed liquid, a dispersion liquid in which copper oxide fine particles coated with a fatty acid, preferably a fatty acid and an ester compound of the fatty acid, are dispersed in a low boiling point solvent is obtained. be able to.
Removal of the high boiling point solvent can be carried out by conventionally known methods such as simple distillation, vacuum distillation, precision distillation, thin film distillation, extraction, and membrane separation.
In the first step, by blending sodium chloride, sodium bromide, etc. together with fatty acid copper and a stabilizer in the high boiling point solvent, the copper compound fine particles dispersed in the dispersion liquid are converted to copper halide fine particles. can be
(分散液の第二の製造方法)
本発明の低沸点溶媒中に脂肪酸、好適には脂肪酸と該脂肪酸のエステル化合物で被覆された銅化合物微粒子が分散された分散液の製造方法は上述した製造方法の他、以下の方法によっても調製することができる。
すなわち、上述した第一の製造方法における第一の工程において、脂肪酸銅に代えて、脂肪酸及び銅化合物の組み合わせを添加する以外は第一の製造方法と同様に行う。
これにより、例えば銅化合物として酢酸銅を使用した場合は、脂肪酸、好適には脂肪酸及び該脂肪酸のエステル化合物が被覆した酢酸銅微粒子が分散した分散液を調製することができる。
この第二の製造方法においても第一の製造方法と同様に、第一の工程で高沸点溶媒と共に水を添加することによって、脂肪酸及び該脂肪酸のエステル化合物が被覆した一価の酢酸銅微粒子を低沸点溶媒中に分散させることが可能になる。
(Second manufacturing method of dispersion liquid)
The method for producing the dispersion in which copper compound fine particles coated with a fatty acid, preferably a fatty acid and an ester compound of the fatty acid are dispersed in the low boiling point solvent of the present invention can be prepared by the following method in addition to the above-described method. can do.
That is, in the first step in the first production method described above, the same procedure as in the first production method is performed except that a combination of a fatty acid and a copper compound is added instead of the fatty acid copper.
As a result, for example, when copper acetate is used as the copper compound, it is possible to prepare a dispersion liquid in which fine copper acetate particles coated with a fatty acid, preferably a fatty acid and an ester compound of the fatty acid are dispersed.
In this second production method, similarly to the first production method, monovalent copper acetate microparticles coated with a fatty acid and an ester compound of the fatty acid are produced by adding water together with a high-boiling solvent in the first step. Dispersion in low-boiling solvents becomes possible.
(分散液の第三の製造方法)
本発明においては、前述した第一及び第二の製造方法における第一の工程で得られた、高沸点溶媒であるグリコール類中に、脂肪酸、好適には脂肪酸と該脂肪酸のエステル化合物で被覆された銅化合物微粒子が分散して成る分散液をそのまま使用することもできる。
すなわち、グリコール類に、脂肪酸銅とサッカリン、或いは脂肪酸と銅化合物とサッカリン、を添加し、これを加熱混合することにより、銅化合物微粒子が分散すると共にサッカリンを含有して成るグリコール分散液を調製してもよい。
この場合においても、上述した製造方法と同様に、グリコール類と共に水を存在させることにより、銅化合物微粒子を一価の銅化合物微粒子として調製することができ、優れた抗ウイルス性を発現することが可能になる。
(Third manufacturing method of dispersion liquid)
In the present invention, the glycols, which are high boiling point solvents, obtained in the first step of the first and second production methods described above are coated with a fatty acid, preferably a fatty acid and an ester compound of the fatty acid. A dispersion in which fine particles of a copper compound are dispersed can also be used as it is.
That is, fatty acid copper and saccharin, or fatty acid, copper compound and saccharin are added to glycols, and the mixture is heated and mixed to prepare a glycol dispersion in which copper compound fine particles are dispersed and saccharin is contained. may
Even in this case, similarly to the production method described above, by allowing water to be present together with the glycols, the copper compound microparticles can be prepared as monovalent copper compound microparticles, and excellent antiviral properties can be exhibited. be possible.
(グリコール類と相溶性を有する非水系溶媒を分散媒とする分散液の製造方法)
本発明においては、グリコール類と相溶性を有する低沸点溶媒、例えばエタノールやイソプロパノール等を分散媒とする場合には、前述した第一及び第二の製造方法により調製した分散液中の低沸点溶媒を加熱除去してペースト状にした後、上記分散媒に再分散させることにより、このような分散液を調製することができる。
前述したとおり、第一及び第二の製造方法においては二相分離により低沸点溶媒に高沸点溶媒中の銅化合物微粒子を抽出させているが、この二相分離では低沸点溶媒及び高沸点溶媒の組み合わせが重要であり、高沸点溶媒に対して相溶性を有する所望の低沸点溶媒中に銅化合物微粒子を分散させることは困難であるが、上述したように、分散液中の低沸点溶媒を除去してペースト状にすることにより、種々の低沸点溶媒に脂肪酸が被覆された酸化銅微粒子が分散した分散液を提供することが可能になる。
加熱混合条件や抽出条件などは、前述した分散液の製造方法における第一工程から第三工程と同様の条件で行うことができる。
(Method for producing a dispersion using a non-aqueous solvent compatible with glycols as a dispersion medium)
In the present invention, when a low boiling point solvent compatible with glycols, such as ethanol or isopropanol, is used as a dispersion medium, the low boiling point solvent in the dispersion liquid prepared by the first and second production methods described above is removed by heating to form a paste, and then re-dispersed in the above dispersion medium to prepare such a dispersion.
As described above, in the first and second production methods, the copper compound fine particles in the high boiling point solvent are extracted by the low boiling point solvent by two-phase separation. The combination is important, and it is difficult to disperse the copper compound fine particles in the desired low boiling point solvent that is compatible with the high boiling point solvent. It is possible to provide dispersion liquids in which copper oxide fine particles coated with fatty acids are dispersed in various low-boiling-point solvents.
Heating and mixing conditions, extraction conditions, and the like can be performed under the same conditions as in the first to third steps in the method for producing a dispersion liquid described above.
(実験例1)
ジエチレングリコールに対してステアリン酸銅2.5重量%と、サッカリン0.05重量%を加え、攪拌しながら加熱した。140℃に達した時点で蒸留水1.0重量%を加え、更に加熱し、190℃に達した時点から2時間加熱した後、ジエチレングリコール分散液を60℃まで冷却した。
次いで、分散剤であるDISPERBYK-2090(ビック・ケミー社製)1.0重量%を溶かした酢酸ブチルを加えて攪拌した。1時間程静置した後に酢酸ブチル層を採取し、亜酸化銅微粒子分散液を得た。
(Experimental example 1)
2.5% by weight of copper stearate and 0.05% by weight of saccharin were added to diethylene glycol and heated while stirring. When the temperature reached 140°C, 1.0% by weight of distilled water was added, the mixture was further heated, and after the temperature reached 190°C, the mixture was heated for 2 hours.
Then, butyl acetate in which 1.0% by weight of DISPERBYK-2090 (manufactured by BYK-Chemie) as a dispersant was dissolved was added and stirred. After allowing to stand still for about 1 hour, the butyl acetate layer was collected to obtain a fine cuprous oxide fine particle dispersion.
(実験例2)
加熱温度を210℃に変更した以外は実験例1と同様に分散液を作製した。
(Experimental example 2)
A dispersion was prepared in the same manner as in Experimental Example 1, except that the heating temperature was changed to 210°C.
(実験例3)
サッカリンの代わりにサリチル酸を添加した以外は実験例1と同様に分散液を作製した。
(Experimental example 3)
A dispersion was prepared in the same manner as in Experimental Example 1, except that salicylic acid was added instead of saccharin.
(実験例4)
加熱温度を170℃に変更した以外は実験例1と同様に分散液を作製した。
(Experimental example 4)
A dispersion was prepared in the same manner as in Experimental Example 1, except that the heating temperature was changed to 170°C.
(実験例5)
ジエチレングリコールをグリセリンに変更した以外は実験例1と同様に分散液を作製した。
(Experimental example 5)
A dispersion was prepared in the same manner as in Experimental Example 1, except that diethylene glycol was changed to glycerin.
(実験例6)
ジエチレングリコールを140℃まで加熱した時点で、水を加えないこと以外は実験例1と同様に分散液を作製した。
(Experimental example 6)
A dispersion liquid was prepared in the same manner as in Experimental Example 1, except that water was not added when diethylene glycol was heated to 140°C.
(実験例7)
酢酸ブチルに市販の亜酸化銅粉末1.0重量%を添加し、撹拌した。
(Experimental example 7)
1.0% by weight of commercially available cuprous oxide powder was added to butyl acetate and stirred.
(実験例8)
酢酸ブチルに市販のステアリン酸銅粉末1.0重量%を添加し、撹拌した。
(Experimental example 8)
1.0% by weight of commercially available copper stearate powder was added to butyl acetate and stirred.
(ゼータ電位評価方法)
ゼータ電位は、大塚電子(株)社製ゼータ電位・粒径・分子量測定システム ELSZ-2000ZSを用いて、測定電圧300Vで測定した。ゼータ電位の絶対値が大きいほど分散安定性が高く、ゼータ電位の絶対値が30(mV)以上であれば分散性は良好である。実験例1~8について測定した。結果を表1に示す。
(Zeta potential evaluation method)
The zeta potential was measured at a measurement voltage of 300 V using a zeta potential/particle size/molecular weight measurement system ELSZ-2000ZS manufactured by Otsuka Electronics Co., Ltd. The larger the absolute value of the zeta potential, the higher the dispersion stability. If the absolute value of the zeta potential is 30 (mV) or more, the dispersibility is good. Experimental Examples 1 to 8 were measured. Table 1 shows the results.
(経時安定性評価方法)
分散液作製1週間後の状態を目視で確認した。粒子の沈殿が無ければ○(経時安定性が高い)、粒子の沈殿があれば×(経時安定性が低い)とした。実験例1~8について確認した。結果を表1に示す。
(Method for evaluating stability over time)
One week after preparation of the dispersion liquid, the state was visually confirmed. If there was no sedimentation of particles, it was evaluated as O (high stability over time), and if there was sedimentation of particles, it was evaluated as x (low stability over time). Experimental Examples 1 to 8 were confirmed. Table 1 shows the results.
(粒子径測定方法)
得られた粒子の粒子径は、SEM画像より画像処理ソフトを用いて測定した。分散液の場合はフィルター濾過により回収した粒子を、市販品の場合は粉末を、日立ハイテクノロジーズ(株)製走査電子顕微鏡S-4800により観察し画像を得た。その画像より(株)Mountech製画像解析式粒度分布ソフトウェアMac-viewを用いて任意の数十個の粒子の平均粒子径を算出した。結果を表1に示す。
(Particle size measurement method)
The particle size of the obtained particles was measured using image processing software from the SEM image. In the case of a dispersion liquid, the particles collected by filter filtration, and in the case of a commercial product, the powder was observed with a scanning electron microscope S-4800 manufactured by Hitachi High-Technologies Corporation to obtain an image. Using the image analysis type particle size distribution software Mac-view manufactured by Mountech Co., Ltd., the average particle size of arbitrary several tens of particles was calculated. Table 1 shows the results.
(溶媒中の脂肪酸エステル化合物の生成有無の確認)
実験例1の分散液において、ジエチレングリコール溶媒とステアリン酸銅から解離したステアリン酸とのエステル化合物の生成有無をIRにより確認した。結果を図1に示す。
(Confirmation of presence or absence of formation of fatty acid ester compound in solvent)
In the dispersion liquid of Experimental Example 1, it was confirmed by IR whether or not an ester compound was formed between the diethylene glycol solvent and the stearic acid dissociated from the copper stearate. The results are shown in FIG.
(溶媒中の脂肪酸エステル化合物の同定)
実験例1の分散液において、生成したエステル化合物の同定を、島津製作所(株)製 GC-MSQP-2010により行った。結果を図2に示す。
(Identification of fatty acid ester compound in solvent)
In the dispersion of Experimental Example 1, the ester compound produced was identified by GC-MSQP-2010 manufactured by Shimadzu Corporation. The results are shown in FIG.
(粒子組成の確認)
実験例1の分散液に関して、X線回折を用いて銅化合物粒子の組成を確認した。結果を図3に示す。
(Confirmation of particle composition)
Regarding the dispersion of Experimental Example 1, the composition of the copper compound particles was confirmed using X-ray diffraction. The results are shown in FIG.
<抗ウイルス性評価>
(分散液の不織布への塗布方法)
得られた分散液90重量%と、バインダー樹脂として光硬化性アクリル系樹脂9.9重量%と、光重合開始剤0.1重量%を混合し塗工液とした。塗工液に未加工の不織布を浸漬し、取り出して余分な液をローラー式絞り機で除去した後、90℃の乾燥機で2分間乾燥した。その後UV照射を10分間行い、亜酸化銅微粒子が固定化された不織布を得た。
実験例1,7,8により得られた不織布について抗ウイルス性評価を行い、実験例1,7,8により得られた不織布について活性酸素発生量を測定した。結果を表2に併せて示す。
<Antiviral evaluation>
(Method of applying dispersion to nonwoven fabric)
90% by weight of the resulting dispersion, 9.9% by weight of a photocurable acrylic resin as a binder resin, and 0.1% by weight of a photopolymerization initiator were mixed to prepare a coating liquid. An unprocessed nonwoven fabric was immersed in the coating liquid, taken out, and excess liquid was removed with a roller wringer, followed by drying with a drier at 90° C. for 2 minutes. After that, UV irradiation was performed for 10 minutes to obtain a nonwoven fabric on which cuprous oxide fine particles were fixed.
The nonwoven fabrics obtained in Experimental Examples 1, 7 and 8 were evaluated for antiviral properties, and the amount of active oxygen generated was measured for the nonwoven fabrics obtained in Experimental Examples 1, 7 and 8. The results are also shown in Table 2.
(不織布の抗ウイルス性評価方法)
1.宿主細胞にウイルスを感染させ、培養後、遠心分離により細胞残渣を除去したものをウイルス懸濁液とする。
2.上記1のウイルス懸濁液を滅菌蒸留水で10倍希釈したものを試験ウイルス懸濁液とする。
3.不織布の試験片0.4gに試験ウイルス懸濁液0.2mLを接種する。
4.25℃2時間放置後、SCDLP培地20mLを加え、ボルテックスミキサーで攪拌し、検体からウイルスを洗い出す。
5.プラーク測定法にてウイルス感染価を測定し、抗ウイルス活性値を算出する。
6.抗ウイルス活性値が3.0以上であれば、そのウイルスに対して十分な抗ウイルス性があると判断できる。
(Method for evaluating antiviral property of nonwoven fabric)
1. A virus suspension is obtained by infecting host cells with a virus, culturing the cells, and removing cell debris by centrifugation.
2. A test virus suspension is obtained by diluting the virus suspension of 1 above 10-fold with sterile distilled water.
3. A 0.4 g piece of nonwoven fabric is inoculated with 0.2 mL of the test virus suspension.
4. After standing at 25°C for 2 hours, add 20 mL of SCDLP medium, stir with a vortex mixer, and wash out the virus from the sample.
5. The virus infectivity titer is measured by the plaque assay method, and the antiviral activity value is calculated.
6. If the antiviral activity value is 3.0 or more, it can be judged that the antiviral activity is sufficient against the virus.
(不織布の活性酸素発生量測定方法)
1.1.5mLのマイクロチューブに0.03gの不織布(1cm×15cm)を入れる。
2.蒸留水10mL、発光試薬(2-メチル-6-p-メトキシフェニルエチニルイミダゾピラジノン溶液)10μLを加え、ルミノメーター(アトー社製 AB-2270 ルミネッセンサーOcta)で発光量を測定し、活性酸素発生量とする。
(Method for measuring active oxygen generation amount of nonwoven fabric)
1. Place 0.03 g of non-woven fabric (1 cm x 15 cm) in a 1.5 mL microtube.
2. 10 mL of distilled water and 10 μL of a luminescence reagent (2-methyl-6-p-methoxyphenylethynylimidazopyrazinone solution) were added, and the amount of luminescence was measured with a luminometer (AB-2270 luminescence sensor Octa manufactured by Atto Co., Ltd.). Generated amount.
本発明の分散液に含まれる銅化合物微粒子は、抗ウイルス性、抗菌性、導電性、紫外線遮蔽性、防汚性等の特性を有し、特に銅化合物粒子が一価の場合には、ノロウイルス等のエンベロープ構造を持たないウイルスに対しても抗ウイルス性を発現することができることから、繊維製品等を構成する樹脂組成物に希釈剤として含有させる、或いは繊維製品等に直接塗布或いは含浸させることにより、繊維製品等に抗ウイルス性を付与することが可能になる。
また、衛生製品以外にも、導電膜、フィルム、金属板、ガラス板、船舶用塗料など各種用途に適用可能である。
更に、分散媒として低沸点溶媒を用いることにより、塗料組成物や樹脂組成物の希釈剤として使用することもでき、これにより塗膜や樹脂成形物に抗ウイルス性を付与することが可能になる。
The copper compound fine particles contained in the dispersion of the present invention have properties such as antiviral properties, antibacterial properties, electrical conductivity, ultraviolet shielding properties, and antifouling properties. Since it can exhibit antiviral properties even against viruses that do not have an envelope structure such as Thus, it becomes possible to impart antiviral properties to textile products and the like.
In addition to sanitary products, it can be applied to various uses such as conductive films, films, metal plates, glass plates, paints for ships, and the like.
Furthermore, by using a low boiling point solvent as a dispersion medium, it can also be used as a diluent for coating compositions and resin compositions, thereby making it possible to impart antiviral properties to coating films and resin moldings. .
Claims (7)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016064740 | 2016-03-28 | ||
JP2016064740 | 2016-03-28 | ||
JP2016247641 | 2016-12-21 | ||
JP2016247641 | 2016-12-21 | ||
JP2017063564A JP6885145B2 (en) | 2016-03-28 | 2017-03-28 | Dispersion liquid, its production method, and copper compound particles |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017063564A Division JP6885145B2 (en) | 2016-03-28 | 2017-03-28 | Dispersion liquid, its production method, and copper compound particles |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2021121577A JP2021121577A (en) | 2021-08-26 |
JP7120382B2 true JP7120382B2 (en) | 2022-08-17 |
Family
ID=62715024
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017063564A Active JP6885145B2 (en) | 2016-03-28 | 2017-03-28 | Dispersion liquid, its production method, and copper compound particles |
JP2021078674A Active JP7120382B2 (en) | 2016-03-28 | 2021-05-06 | Method for producing copper compound fine particle-containing dispersion |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017063564A Active JP6885145B2 (en) | 2016-03-28 | 2017-03-28 | Dispersion liquid, its production method, and copper compound particles |
Country Status (1)
Country | Link |
---|---|
JP (2) | JP6885145B2 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6885146B2 (en) * | 2016-03-28 | 2021-06-09 | 東洋製罐グループホールディングス株式会社 | Antiviral molded body |
CN108882701A (en) | 2016-03-28 | 2018-11-23 | 东洋制罐集团控股株式会社 | Dispersion liquid, its production method and copper compound particle |
JP7478138B2 (en) * | 2019-04-03 | 2024-05-02 | 東洋製罐グループホールディングス株式会社 | Metallic copper fine particle-containing resin composition and method for producing same |
JP7461727B2 (en) * | 2019-09-30 | 2024-04-04 | 東洋アルミエコープロダクツ株式会社 | Antibacterial base film, antibacterial food containers and antibacterial food sheets |
JP7229215B2 (en) * | 2020-10-21 | 2023-02-27 | イビデン株式会社 | antiviral component |
JP7229216B2 (en) * | 2020-10-21 | 2023-02-27 | イビデン株式会社 | antiviral component |
JP7262687B1 (en) * | 2021-07-14 | 2023-04-21 | 三井金属鉱業株式会社 | Copper oxide particles and antibacterial or antiviral composition containing the same |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004155622A (en) | 2002-11-08 | 2004-06-03 | Asahi Kasei Corp | Process for manufacturing cuprous oxide particulate |
JP2006176876A (en) | 2004-11-29 | 2006-07-06 | Mitsubishi Materials Corp | Extraction method for metal particulate or the like, and its application |
JP2013241643A (en) | 2012-05-18 | 2013-12-05 | Toyo Seikan Group Holdings Ltd | Dispersion liquid containing silver ultrafine particle, and method of manufacturing the same |
JP2015120896A (en) | 2013-11-22 | 2015-07-02 | 東洋製罐グループホールディングス株式会社 | Curable resin composition having antibacterial property |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5423053B2 (en) * | 2008-02-29 | 2014-02-19 | 東洋製罐株式会社 | Method for producing fatty acid-modified metal ultrafine particle dispersion |
JP5227828B2 (en) * | 2009-02-17 | 2013-07-03 | 株式会社日立製作所 | Method for producing oxidation-resistant copper fine particles and joining method using the same |
JP5311147B2 (en) * | 2010-08-25 | 2013-10-09 | 株式会社豊田中央研究所 | Surface-coated metal nanoparticles, production method thereof, and metal nanoparticle paste including the same |
JP5848552B2 (en) * | 2011-08-29 | 2016-01-27 | 日立金属株式会社 | Method for producing copper fine particle dispersion, method for producing copper fine particle, copper fine particle dispersion and copper fine particle |
JP5812488B2 (en) * | 2011-10-12 | 2015-11-11 | 昭和電工株式会社 | Antibacterial antiviral composition and method for producing the same |
JP5943611B2 (en) * | 2012-01-13 | 2016-07-05 | 三井金属鉱業株式会社 | Cuprous oxide particles and method for producing the same |
JP5194185B1 (en) * | 2012-06-20 | 2013-05-08 | 株式会社Nbcメッシュテック | Antiviral composition |
JP2014148732A (en) * | 2013-02-04 | 2014-08-21 | Yamagata Univ | Novel coated copper fine particle and production method thereof |
CN104936901B (en) * | 2013-02-27 | 2016-10-12 | 松下知识产权经营株式会社 | Coating agent composition and antibacterial/antiviral property component |
JP6243190B2 (en) * | 2013-10-30 | 2017-12-06 | 東洋製罐グループホールディングス株式会社 | Antimicrobial metal ultrafine particle-containing dispersion and method for producing the same |
JP6885146B2 (en) * | 2016-03-28 | 2021-06-09 | 東洋製罐グループホールディングス株式会社 | Antiviral molded body |
-
2017
- 2017-03-28 JP JP2017063564A patent/JP6885145B2/en active Active
-
2021
- 2021-05-06 JP JP2021078674A patent/JP7120382B2/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004155622A (en) | 2002-11-08 | 2004-06-03 | Asahi Kasei Corp | Process for manufacturing cuprous oxide particulate |
JP2006176876A (en) | 2004-11-29 | 2006-07-06 | Mitsubishi Materials Corp | Extraction method for metal particulate or the like, and its application |
JP2013241643A (en) | 2012-05-18 | 2013-12-05 | Toyo Seikan Group Holdings Ltd | Dispersion liquid containing silver ultrafine particle, and method of manufacturing the same |
JP2015120896A (en) | 2013-11-22 | 2015-07-02 | 東洋製罐グループホールディングス株式会社 | Curable resin composition having antibacterial property |
Also Published As
Publication number | Publication date |
---|---|
JP6885145B2 (en) | 2021-06-09 |
JP2021121577A (en) | 2021-08-26 |
JP2018100255A (en) | 2018-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102168357B1 (en) | Dispersion and its manufacturing method, and copper compound particles | |
JP7120382B2 (en) | Method for producing copper compound fine particle-containing dispersion | |
JP6885146B2 (en) | Antiviral molded body | |
JP6984122B2 (en) | Dispersion with antiviral properties | |
JP6512255B2 (en) | Metal copper fine particles and method for producing the same | |
KR102313277B1 (en) | Metallic copper fine particles and manufacturing method thereof | |
CN108003669A (en) | Automatically cleaning photocatalyst CT catalyst composite coating, coating and product | |
JPWO2014141812A1 (en) | Antibacterial antiviral photocatalytic titanium oxide, antibacterial antiviral photocatalytic titanium oxide slurry dispersed in neutral region, and production method thereof | |
TW201446901A (en) | Coating-agent composition and antimicrobial/antiviral member | |
WO2016081509A1 (en) | Compositions comprising diatom frustules and applications thereof | |
JP2009226400A (en) | Method of manufacturing dispersion of metallic ultrafine particle modified by fatty acid | |
WO2020204118A1 (en) | Fine particle powder of metallic copper and method for manufacturing same | |
JP7478138B2 (en) | Metallic copper fine particle-containing resin composition and method for producing same | |
JP5291980B2 (en) | Core-shell mesoporous silica particles | |
JP2009131756A (en) | Method for producing titanium oxide-based deodorant | |
JP2020169167A (en) | Antiviral agent comprising metal copper fine particle | |
JP6743798B2 (en) | Antiviral agent | |
WO2023190471A1 (en) | Metal microparticle-containing dispersion exhibiting antimicrobial property with excellent long-term stability | |
DE102006032759B4 (en) | Stable suspensions of crystalline ZrO2 particles from hydrothermally treated sol-gel precursor powders | |
JP2023152901A (en) | Antimicrobial composition containing metal fine particle | |
JP5869846B2 (en) | Titanium oxide coating solution | |
JP2011225694A (en) | Water-in-oil type emulsion using super hydrophobic powder as dispersant and method for producing the same | |
JP2005224727A (en) | Modified photocatalyst |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20210506 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20220225 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20220301 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220422 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20220705 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20220718 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7120382 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |